
Another Chinese biotech files to go public in Hong Kong; A new ROR1 ADC deal
Plus, news about Harmony Biosciences and Reverb Therapeutics:
Genuine Biotech files for HKEX listing: The drug developer, which has multiple locations in China,
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.